NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma

Publication Date

2023

Content Type

Article

PubMed ID:

38024244

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS